More about

Intraocular Pressure

News
October 20, 2020
1 min read
Save

Sustained-release glaucoma medications needed to reduce treatment burden

Sustained-release glaucoma medications needed to reduce treatment burden

Between poor patient adherence and the inherent IOP peaks and troughs associated with eye drop-managed glaucoma, sustained-release medications are greatly needed, a presenter at the virtual OSN New York meeting said.

News
October 08, 2020
2 min read
Save

MicroPulse transscleral cyclophotocoagulation an option in refractory glaucoma

Patients with uncontrolled refractory glaucoma who underwent MicroPulse transscleral cyclophotocoagulation experienced a mean 28.6% IOP reduction from baseline at 2 years, according to a study.

News
October 08, 2020
3 min read
Save

Citicoline drops may slow glaucoma progression in some patients

Citicoline drops may slow glaucoma progression in some patients

Adding citicoline eye drops to IOP-lowering medications might reduce glaucoma progression in patients with worsening damage despite well-controlled IOP, according to a study.

News
September 25, 2020
1 min read
Save

Trabectome may yield advantage in early postop period

When combined with cataract surgery, both Trabectome and a single Glaukos iStent reduce IOP and medication burden in glaucoma patients, but Trabectome may yield better results in the early postoperative period, according to a study.

News
September 24, 2020
1 min read
Save

KPI-121 0.25% safe, well-tolerated in patients with dry eye disease

KPI-121 0.25% safe, well-tolerated in patients with dry eye disease

The results of four randomized, double-masked, vehicle-controlled trials showed KPI-121 0.25% is safe and well tolerated with no unexpected treatment-related adverse events in patients with dry eye disease, according to a study.

News
September 24, 2020
1 min read
Save

Roclanda displays non-inferiority in phase 3b trial

Interim results from a phase 3b clinical trial in Europe showed Roclanda was non-inferior to Ganfort, according to a press release.

News
September 16, 2020
1 min read
Save

Enrollment complete for phase 2 razuprotafib trial in glaucoma

Aerpio Pharmaceuticals has completed enrollment in its phase 2 razuprotafib trial for patients with elevated IOP associated with open-angle glaucoma or ocular hypertension, according to a press release.

News
September 15, 2020
2 min read
Save

Nonvalved aqueous drainage implant reduces IOP, glaucoma medications

Nonvalved aqueous drainage implant reduces IOP, glaucoma medications

A low-cost nonvalved aqueous drainage implant significantly reduced IOP and glaucoma medication use in patients with refractory glaucoma, according to a retrospective review.

News
September 07, 2020
2 min watch
Save

VIDEO: Hydrus microstent sales grow, backed by data

VIDEO: Hydrus microstent sales grow, backed by data

In this Healio Video Perspective, Dave Van Meter, CEO of Ivantis, discusses the global launch of the Hydrus microstent for the treatment of glaucoma, and the data accumulated with the device over more than 4 years.

News
September 07, 2020
2 min watch
Save

VIDEO: Glaukos restates commitment to physicians and patients during pandemic

VIDEO: Glaukos restates commitment to physicians and patients during pandemic

In this Healio Video Perspective, Chris Calcaterra, chief operating officer at Glaukos Corp., discusses the company’s commitment to ophthalmologists and their patients throughout the coronavirus pandemic and going forward.

View more